Alachua Government Services

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Alachua Government Services sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials none currently recruiting 12 completed top decile by trial count

Alachua Government Services: 12 sponsored US clinical trials, none currently recruiting.

Alachua Government Services sponsors 12 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 12 completed. 4 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Post Traumatic Stress Disorder, with 1 trials.

Top-decile sponsor footprint

Alachua Government Services ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

12 of 12 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

12 total, page 1 of 1

COMPLETED NA

Evaluating Technologies for Point-of-Care Blood Collections by Patients

NCT06507566

COMPLETED Phase 1

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

NCT04592549

COMPLETED Phase 1

Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects

NCT04171115

COMPLETED Phase 1

Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults

NCT03046550

COMPLETED Phase 3

Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)

NCT01773928

COMPLETED NA

Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder

NCT01492699

COMPLETED Phase 1

Reverse Genetic H9N2 Influenza Vaccine Study in Adults

NCT01320696

COMPLETED Phase 1

Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults

NCT01258062

COMPLETED Phase 3

Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection

NCT00800605

COMPLETED Phase 3

Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

NCT00782431

COMPLETED Phase 1

Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant)

NCT00783926

COMPLETED Phase 3

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

NCT00566345

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 3 4

How the Alachua Government Services archive is shaped

12 indexed studies, none listed as recruiting (0% open); 12 completed (100%).

Phase mix: 4 late (III/IV) vs 6 early (I/II) (balanced across stages).

Top condition: Post Traumatic Stress Disorder (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Alachua Government Services: archived-pipeline peers nationwide

Peers matched on 12 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Alachua Government Services sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20% Total trials Recruiting share Alachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsApnimed10xBio22nd Century Group23andMe3-C Institute for Social Development
Alachua Government Services sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Alachua Government Services sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Alachua Government Services page

12 registered trials is a research-attention snapshot, not an endorsement of Alachua Government Services or any single study.

  • None of Alachua Government Services's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Post Traumatic Stress Disorder is the condition Alachua Government Services studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Post Traumatic Stress Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Alachua Government Services pipeline card: 12 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.